Abstract:The development of injectable integrin alpha(v)beta(3)/alpha(IIb)beta(3) dual antagonists attracts much attention of research for treating of acute ischemic diseases in recent years. In this work, based on a dataset composed of 102 tricyclic piperazine/piperidine furnished dual alpha(v)beta(3) and alpha(IIb)beta(3) antagonists, a variety of in silico modeling approaches including the comparative molecular field analysis (CoMFA), comparative similarity indices analysis (CoMSIA), and molecular docking were applied to reveal the requisite 3D structural features impacting the biological activities. Our statistical results show that the ligand-based 3D-QSAR models for both the alpha(v)beta(3) and alpha(IIb)beta(3) studies exhibited satisfactory internal and external predictability, i.e., for the CoMFA models, results of Q(2) = 0.48, R-ncv(2) = 0.87, R-pred(2) = 0.71 for alpha(v)beta(3) and Q(2) = 0.50, R-ncv(2) = 0.85, R-pred(2) = 0.72 for alpha(IIb)beta(3) analysis were obtained, and for the CoMSIA ones, the outcomes of Q(2) = 0.55, R-ncv(2) = 0.90, R-pred(2) = 0.72 for alpha(v)beta(3) and Q(2) = 0.52, R-ncv(2) = 0.88, R-pred(2) = 0.74 for alpha(IIb)beta(3) were achieved respectively. In addition, through a comparison between 3D-QSAR contour maps and docking results, it is revealed that that the most crucial interactions occurring between the tricyclic piperazine/piperidine derivatives and alpha(v)beta(3)/alpha(IIb)beta(3) receptor ligand binding pocket are H-bonding, and the key amino acids impacting the interactions are Arg214, Asn215, Ser123, and Lys253 for alpha(v)beta(3), but Arg214, Asn215, Ser123 and Tyr190 for alpha(IIb)beta(3) receptors, respectively. Halogen-containing groups at position 15 and 16, benzene sulfonamide substituent at position 23, and the replacement of piperazine with 4-aminopiperidine of ring B may increase the alpha(v)beta(3)/alpha(IIb)beta(3) antagonistic activity. The potencies for antagonists to inhibit isolated alpha(v)beta(3) and alpha(IIb)beta(3) are linear correlated, indicating that similar interaction mechanisms may exist for the series of molecules. To our best knowledge this is the first report on 3D-QSAR modeling of these dual alpha(v)beta(3)/alpha(IIb)beta(3) antagonists. The results obtained should provide information for better understanding of the mechanism of antagonism and thus be helpful in design of novel potent dual alpha(v)beta(3)/alpha(IIb)beta(3) antagonists. (C) 2011 Elsevier Inc. All rights reserved.

Prediction of Anti-adhesion Activities of Qishen Yiqi Dripping Pills by Quantitative Structure-activity Relationship Modle

Quantitative prediction of enantioselectivity of Candida antarctica lipase B by combining docking simulations and quantitative structure-activity relationship (QSAR) analysis

High accuracy prediction of dipeptide angiotensin-converting enzyme (ACE) inhibitory activity by improving the credibility of the 3D-quantita- tive structure-activity relationship (3D-QSAR) model database and investigating inhibition mechanism

Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.

Study on three-dimensional quantitative structure-activity relationships of N-sub tituted-4-subtituted phenylpiperazine-1-acetic amide series as α1- adrenoceptor antagonists

High accuracy prediction of dipeptide angiotensin-converting enzyme (ACE) inhibitory activity by improving the credibility of the 3D-quantitative structure-activity relationship (3D-QSAR) model database and investigating inhibition mechanism

Activity Prediction of Schiff Base Compounds Using Improved QSAR Models of Cinnamaldehyde Analogues and Derivatives

Activity Prediction of Angiotensin Converting Enzyme Inhibitors Based on the Quantitative Structure-Activity Relationship Method

Quantitative Structure-Activity Relationship of 2-Alkyl-4-(biphenylylmethoxy) Pyridine Derivatives with AT1 Receptor Antagonistic Activity

3D-QSAR and Docking Study on 3-Benzimidazol-2-ylhydroquinolin-2-one Derivatives As VEGFR-2 Tyrosine Kinase Inhibitors

Quantum Chemical and Molecular Dynamics Studies of Imidazoline Derivatives As Corrosion Inhibitor and Quantitative Structure–activity Relationship (QSAR) Analysis Using the Support Vector Machine (SVM) Method

Three dimensional quantitative structure activity relationship of P45017α inhibitors of 17-substituted steroids

QSAR as applied in modeling and predicting binding affinities between the human amphiphysin-I SH3 domains and its peptides ligands

Enhanced Replacement Method‐based Quantitative Structure–Activity Relationship Modeling and Support Vector Machine Classification of 4‐anilino‐3‐quinolinecarbonitriles As Src Kinase Inhibitors

An Investigation on the Quantitative Structure-Activity Relationships of the Anti-Inflammatory Activity of Diterpenoid Alkaloids

Qsar Studies of Aminopeptidase N/Cd13 (apn) Inhibitors with the Scaffold 3-Phenylpropane-1,2-diamine and Molecular Docking

Predicting the Activity of Peptides Based on Amino Acid Information

Robust and predictive 3D-QSAR models for predicting the activities of novel oxadiazole derivatives as multifunctional anti-Alzheimer agents

Towards Cheminformatics-Based Estimation of Drug Therapeutic Index: Predicting the Protective Index of Anticonvulsants Using a New Quantitative Structure-Index Relationship Approach.

Studies of Tricyclic Piperazine/piperidine Furnished Molecules As Novel Integrin Αvβ3/αiibβ3 Dual Antagonists Using 3D-QSAR and Molecular Docking.

Three-dimensional Quantitative Structural-Activity Relationship and Molecular Dynamics Study of Multivariate Substituted 4-Oxyquinazoline HDAC6 Inhibitors